Macrophage migration inhibitory factor: a regulator of glucocorticoid activity with a critical role in inflammatory disease

被引:105
作者
Donnelly, SC [1 ]
Bucala, R [1 ]
机构
[1] PICOWER INST MED RES,MANHASSET,NY 11030
来源
MOLECULAR MEDICINE TODAY | 1997年 / 3卷 / 11期
关键词
D O I
10.1016/S1357-4310(97)01133-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Macrophage migration inhibitory factor (MIF) was one of the first cytokines to be identified, In the early 1990s it was 'rediscovered' as a hormone that is secreted by the anterior pituitary gland and counter-regulates the anti inflammatory effects of glucocorticoids, We now know that glucocorticoids stimulate the release of MIF from T cells and macrophages; this appears to be a physiological response to override the effects of glucocorticoids at the inflammatory site, However, this response can become pathological in acute respiratory distress syndrome (ARDS), in which high concentrations of MIF in the alveoli might contribute to ARDS pathogenesis, New insights into the structure and function of MIF, and the possibility of increasing the efficacy of glucocorticoids in the clinic by inhibiting MIF, are discussed in this review.
引用
收藏
页码:502 / 507
页数:6
相关论文
共 29 条
  • [1] ABNORMAL GLUCOCORTICOID RECEPTOR ACTIVATOR PROTEIN-1 INTERACTION IN STEROID-RESISTANT ASTHMA
    ADCOCK, IM
    LANE, SJ
    BROWN, CR
    LEE, TH
    BARNES, PJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (06) : 1951 - 1958
  • [2] ADCOCK IM, 1995, Q J MED, V88, P455
  • [3] IMMUNOSUPPRESSION BY GLUCOCORTICOIDS - INHIBITION OF NF-KAPPA-B ACTIVITY THROUGH INDUCTION OF I-KAPPA-B SYNTHESIS
    AUPHAN, N
    DIDONATO, JA
    ROSETTE, C
    HELMBERG, A
    KARIN, M
    [J]. SCIENCE, 1995, 270 (5234) : 286 - 290
  • [4] An essential regulatory role for macrophage migration inhibitory factor in T-cell activation
    Bacher, M
    Metz, CN
    Calandra, T
    Mayer, K
    Chesney, J
    Lohoff, M
    Gemsa, D
    Donnelly, T
    Bucala, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) : 7849 - 7854
  • [5] Bacher M, 1997, AM J PATHOL, V150, P235
  • [6] GLUCOCORTICOID RESISTANCE IN ASTHMA
    BARNES, PJ
    GREENING, AP
    CROMPTON, GK
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (06) : S125 - S140
  • [7] MIF IS A PITUITARY-DERIVED CYTOKINE THAT POTENTIATES LETHAL ENDOTOXEMIA
    BERNHAGEN, J
    CALANDRA, T
    MITCHELL, RA
    MARTIN, SB
    TRACEY, KJ
    VOELTER, W
    MANOGUE, KR
    CERAMI, A
    BUCALA, R
    [J]. NATURE, 1993, 365 (6448) : 756 - 759
  • [8] PURIFICATION, BIOACTIVITY, AND SECONDARY STRUCTURE-ANALYSIS OF MOUSE AND HUMAN MACROPHAGE-MIGRATION INHIBITORY FACTOR (MIF)
    BERNHAGEN, J
    MITCHELL, RA
    CALANDRA, T
    VOELTER, W
    CERAMI, A
    BUCALA, R
    [J]. BIOCHEMISTRY, 1994, 33 (47) : 14144 - 14155
  • [9] An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction
    Bernhagen, J
    Bacher, M
    Calandra, T
    Metz, CN
    Doty, SB
    Donnelly, T
    Bucala, R
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (01) : 277 - 282
  • [10] CONTROL OF CACHECTIN (TUMOR-NECROSIS-FACTOR) SYNTHESIS - MECHANISMS OF ENDOTOXIN RESISTANCE
    BEUTLER, B
    KROCHIN, N
    MILSARK, IW
    LUEDKE, C
    CERAMI, A
    [J]. SCIENCE, 1986, 232 (4753) : 977 - 980